Yanıklı hastalarda anestezi

Yanık, vücudun dış ortamla ilişkisini sağlayan derinin bütünlüğünün termal nedenlerle bozulmasıdır. Primer olarak etkilenen organ deri olmasına karşın, diğer tüm organ ve sistemlerde de komplikasyonlar oluşabilmekte ve belirgin morbidite ve mortaliteye yol açabilmektedir. Yanıklı hastaların tedavisi ve anestezi uygulamaları multidisipliner yaklaşımı ve işbirliğini gerektirir. Anestezi uygulayacak kişinin, yanıklarda oluşabilecek fizyopatolojik değişiklikleri ve anestezide kullanılan farmakolojik ajanlara yanıtları iyi bilmesi gerekir.

Anesthesia in burn injury patients

Burn injury is deterioration of the skin because of the thermal reasons that is in relationship with external environment. Although skin is the primarily affected organ, complications can occur in all other organs and systems and can lead to significant morbidity and mortality. Treatment and anesthesia management of the patients with burn injuries requires a multidisciplinary approach and cooperation. The person who is going to apply anesthesia should know the pathophysiological changes in burn injuries and person’s responses to pharmacological agents used in anesthesia.

PDF

___

1 Griffs RW. Management of multiple casualties with burns. BMJ 1985; 291:917-8.
2 Nebraska Burn Institute. Advanced Burn Life Support Providers Manual. Lincoln NE: Nebraska Burn Institute, 1987.
3 Goldfarb JW. The burn patient, Air Medical Crew National Standarts Curriculum, Phoenix, ASHBEAMS, 1988.
4 Arturson G. Pathophysiology of the burn wound and pharmacological treatment. The Rudi Hermans Lecture, 1995. Burns. 1996; 22: 255-274.
5 Finnerty CC, Herndon DN, Przkora R, et al. Cytokine expression profile over time in severely burned pediatric patients. Shock. 2006; 26: 13-19.
6 Jeschke MG, Chinkes DL, Finnerty CC, et al. Pathophysiologic response to severe burn injury. Ann Surg. 2008; 248: 387-401.
7 Monafo WW. Initial management of burns. N Engl J Med. 1996; 335: 1581-1586.
8 Enkhbaatar P, Traber DL. Pathophysiology of acute lung injury in combined burn and smoke inhalation injury. Clin Sci (Lond). 2004; 107: 137-143.
9 Murakami K, Traber DL. Pathophysiological basis of smoke inhalation injury. News Physiol Sci. 2003; 18: 125-129.
10 Nieman GF, Clark WR Jr, Wax SD, et al. The effect of smoke inhalation on pulmonary surfactant. Ann Surg. 1980; 191: 171-181.
11 Darling GE, Keresteci MA, Ibanez D, et al. Pulmonary complications in inhalation injuries with associated cutaneous burn. J Trauma. 1996; 40: 83-89.
12 Madnani DD, Steele NP, de Vries E. Factors that predict the need for intubation in patients with smoke inhalation injury. Ear Nose Throat J. 2006; 85: 278-280.
13 Turnage RH, Nwariaku F, Murphy, J, et al. Mechanisms of pulmonary microvascular dysfunction during severe burn injury. World J Surg. 2002; 26: 848-853.
14 Aikawa N, Wakabayashi G, Ueda M, et al. Regulation of renal function in thermal injury. J Trauma. 1990; 30: S174-S178.
15 Pereira CT, Murphy KD, Herdon DN. Altering metabolism. J Burn Care Rehabil. 2005; 26: 194-199.
16 Jeschke MG, Mlcak RP, Finnerty CC, et al. Burn size determines the inflammatory and hypermetabolic response. Crit Care. 2007; 11: R90.
17 Hart DW, Wolf SE, Mlcak R, et al. Persistence of muscle catabolism after severe burn. Surgery. 2000; 128: 312-319.
18 Jeschke MG, Micak RP, Finnerty CC, et al. Changes in liver function and size after a severe thermal injury. Shock. 2007; 28: 172-177.
19 Lawrence C, Atac B. Hematologic changes in massive burn injury. Crit Care Med. 1992; 20: 1284-1288.
20 Venter M, Rode H, Sive A, et al. Enteral resuscitation and early enteral feeding in children with majör burns – effect on McFarlane response to stress. Burns. 2007; 33: 464-471.
21 Burke BA, Latenser BA. Defining intraabdominal hypertension and abdominal compartment syndrome in acute thermal injury: a multicenter survey. J Burn Care Res. 2008; 29: 580-584.
22 Antoon AY, Volpe JJ, Crawford JD. Burn encephalopathy in children. Pediatrics. 1972; 50: 609-616.
23 Gueugniaud PY, Jauffray M, Bertin-Maghit M, et al. Cerebral oedema after extensive thermal injury: prognostic significance of early intracranial and cerebral perfusion pressures. Ann Burns Fire Disast. 1997; 10: 72-77.
24 Watkins WD, Leslie JB, DeBruijn NP. Pharmacolgic principles. Eds.: Miller RD. Anesthesia, New York, Churchill Livingstone, 1986, p. 55-73.
25 Martyn JA, Abernethy DR, Greenblatt DJ. Plasma protein binding of drugs after severe burn injury. Clin Pharmacol Ther. 1984; 35: 535- 539.
26 Zini R, Riant P, Barre J, Tillement JP. Diseaseinduced variations in plasma protein levels. Implications for drug dosege regimens (Part I). Clin Pharmacokinet. 1990; 19: 147-159.
27 Martyn JAJ, Szyfelbein SK, Ali HH. Increased dtubocurarine requirement following majör thermal injury. Anesthesiology. 1980; 52: 352-356.
28 Moncrief JA. Complications of burns. Ann Surg. 1958; 147: 443-475.
29 Schaner PJ, Brown RL, Kirksey TD, et al. Succinylcholine-induced hyperkalemia in burned patients. Anesth Analg. 1969; 48: 764-770.
30 McCaughey TJ. Hazards of anesthesia for the burned child. Can Anaesth Soc J. 1962; 9: 220- 233.
31 Yentis SM. Suxamethonium and hyperkalemia. Anesth Intensive Care. 1990; 18: 92-101.
32 Martyn JA, Matteo RS, Szyfelbein SK, Kaplan RF. Unprecedented resistance to neuromuscular blocking effects of metocurine with persistence after complete recovery in a burned patient. Anesth Analg. 1982; 61: 614- 617.
33 Martyn JA, Greenblatt DJ, Quinby WC. Diazepam kinetics in patients with severe burns. Anesth Analg. 1983; 62: 293-297.
34 Sokoll MD, Gergis SD. Antibiotics and neuromuscular function. Anesthesiology. 1981; 55: 148-151.
35 Grande CM, Stene JK, Bernhard WN. Airway management: Considerations in the trauma patient. Crit Care Clin. 1990; 6: 37-59.
36 Sefton EJ, Boulton-Jones JR, Anderton D, et al. Enteral feeding in patients with majör burn injury: the use of naso-jejunal feeding after the failure of nasogastric feeding. Burns. 2002; 28: 386-390.
37 Kyriacou PA. Pulse oximetry in the oesophagus. Physiol Meas. 2006; 27: R1-R35.
38 Szyfelbein SK, Drop LJ, Martyn JA. Persistent ionized hypocalcemia in patients during resuscitation and recovery phases of body burns. Crit Care Med. 1981; 9: 454-458.
39 Johnston WE. Complications from the use of pulmonary artery catheters. Eds.: Lumb PD, Bryan-Brown CW. Complications in Critical Care Medicine, Chicago, IL: Year Book Medical Publishers, Inc, 1988.
40 Lamb JD. Anaesthetic considerations for majör thermal injury. Can Anaesth Soc. 1985; 32: 84-92.
41 Moran KT, O'Reilly TJ, Furman WR. A new algorithm for calculation of blood loss in excisional brn surgery. Am Surg. 1988; 54: 207- 210.
42 Shelly MP, Lloyd GM, Park GR. A review of the mechanisms and methods of humudification of inspired gases. Intens Care Med. 1988; 14: 1-9.
43 Cote CJ, Petkau AJ. Thiopental requirements may be increased in children reanesthetized at least one year after recovery from extensive thermal injury. Anesth Analg. 1985; 64: 1156- 1160.
44 Martyn JA, Richtsfeld M. Succinylcholineinduced hyperkalemia in acquired pathologic states: etiologic factors and molecular mechanisms. Anesthesiology. 2006; 104: 158-169.
45 Fuzaylov G, Fidkowski CW. Anesthetic considerations for majör burn injury in pediatric patients. Pediatric Anesthesia. 2009; 19: 202-211.
46 White PF, Way WL, Trevor AJ. Ketamine-its pharmacology and therapeutics uses. Anesthesiology. 1982; 56: 119-136.
47 Herman RA, Veng-Pedersen P, Miotto J, et al. Pharmacokinetics of morphine sulfate in patients with burns. J Burn Care Rehabil. 1994; 15: 95-103.
48 Han T, Harmatz JS, Greenblatt DJ, et al. Fentanyl clearance and volume of distribution are increased in patients with majör burns. J Clin Pharmacol. 2007; 47: 674-680.
49 Reyneke CJ, James MF, Johnson R. Alfentanil and propofol infusions of surgery in the burned patients. Br J Anaesth. 1989; 63: 418-422.
50 Baum VC, Yemen TA, Baum LD. Immediate 8 % sevoflurane induction in children: A comparison with incremental halothane. Anesth Analg. 1997; 85: 313-316.
51 Gregoretti S, Gelman S, Dimick A, Bradley EL Jr. Hemodynamic changes and oxygen consumption in burned patients during enflurane or isoflurane anesthesia. Anesth Analg. 1989; 69: 431-436.
52 Sahlman L, Henriksson BA, Martner J, Ricksten SE. Effects of halothane, enflurane, and isoflurane on coronary vascular tone, myocardial performance, and oxygen consumption during controlled changes in aortic and left atrial pressure. Studies on isolated working rat hearts in vitro. Anesthesiology. 1988; 69: 1-10.
53 Desai MH, Herndon DN, Broemeling L, et al. Early burn wound excision significantly reduces blood loss. Ann Surg. 1990; 211: 753-759.
54 Losee JE, Fox I, Hua LB, et al. Transfusion-free pediatric burn surgery. Ann Plast Surg. 2005; 54: 165-171.
55 Crabtree JH, Bowser BH, Campbell JW, et al. Energy metabolism in anesthetized children with burns. Am J Surg. 1980; 140: 832-835.
56 Martyn JA. Clinical pharmacology and drug therapy in the burned patient. Anesthesiology. 1986; 65: 67-75.
57 Ashburn MA. Burn pain: The management of procedure related pain. J Burn Care Rehabil. 1995; 16: 365-371.
58 Choiniere M, Grenier R, Paquette C. Patientcontrolled analgesia: A double blind study in burn patients. Anaesthesia. 1992; 47: 467-472.
59 Wilson GR, Tomlinson P. Pain relief in burnshow we do it. Burns. 1988; 14: 331-332.
60 Martyn JAJ, Greenblatt DS, Qinbay WC. Diazepam kinetics following burns. Anesth Analg. 1983; 62: 293-297.
61 Greenblatt DJ, Locniskar A, Ochs HR, Lauren PM. Automated gas chromatography for studies of midazolam pharmacokinetics. Anesthesiology. 1981; 55: 176-179.
62 McClure JH, Brown DT, Wildsmith JAW. Comparison of the IV administration of midazolam and diazepam as sedation during spinal anesthesia. Br J Anaesth. 1983; 55: 1089-1093.
63 Johnson CE, Ericsson F. Impairment of renal function after treatment of a burn patient with diclofenac, a non-steroidal anti-inlammatory drug. Burns. 1995; 21: 471-473.